PAI
ProQuest Associates IV Portfolio holdings
AUM
$53M
This Quarter Return
-11.87%
1 Year Return
+3.35%
3 Year Return
+116.54%
5 Year Return
–
10 Year Return
–
AUM
$423M
AUM Growth
+$423M
(-13%)
Cap. Flow
-$998K
Cap. Flow
% of AUM
-0.24%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Savara
SVRA
|
$740K |
| 2 |
IMDZ
Immune Design Corp.
IMDZ
|
$258K |
Sector Composition
| 1 | Healthcare | 86.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGRX
1
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $354M | 83.76% |
4,780,188
| – | – |
|
|
AGRX
2
DELISTED
Agile Therapeutics, Inc
AGRX
| $31.5M | 7.45% |
4,668,663
| – | – |
|
|
IMDZ
3
DELISTED
Immune Design Corp.
IMDZ
| $23.9M | 5.67% |
1,962,720
-21,138
| -1% | -$258K |
|
|
ANTH
4
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $11.6M | 2.74% |
1,900,000
| – | – |
|
|
ZSAN
5
DELISTED
Zosano Pharma Corporation
ZSAN
| $910K | 0.22% |
229,759
| – | – |
|
|
6
Savara
SVRA
$567M
| $740K | 0.18% |
1,275,925
-1,275,926
| -50% | -$740K |
|